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Abstract
Hepadnavirus at very low doses establishes in woodchucks asymptomatic, serologically undetectable but molecularly
evident persistent infection. This primary occult infection (POI) preferentially engages the immune system and initiates
virus-specific T cell response in the absence of antiviral antibody induction. The current study aimed to determine whether
POI with time may culminate in serologically identifiable infection and hepatitis, and what are, if any, its pathological
consequences. Juvenile woodchucks were intravenously injected with inocula containing 10 or 100 virions of woodchuck
hepatitis virus (WHV) to induce POI and followed for life or up to 5.5 years thereafter. All 10 animals established molecularly
detectable infection with virus DNA in serum (,100–200 copies/mL) and in circulating lymphoid cells, but serum WHV
surface antigen and antibodies to WHV core antigen remained undetectable for life. By approximately 2.5–3.5 years post-
infection, circulating virus transiently increased to 103 copies/mL and virus replication became detectable in the livers, but
serological markers of infection and biochemical or histological evidence of hepatitis remained undetectable. Nonetheless,
typical hepatocellular carcinoma (HCC) developed in 2/10 animals. WHV DNA integration into hepatic and lymphatic system
genomes was identified in 9/10 animals. Virus recovered from the liver virus-negative or virus-positive phases of POI
displayed the wild-type sequence and transmitted infection to healthy woodchucks causing hepatitis and HCC. In summary,
for the first time, our data demonstrate that an asymptomatic hepadnaviral persistence initiated by very small amounts of
otherwise pathogenic virus, advancing in the absence of traditional serological markers of infection and hepatitis, coincides
with virus DNA integration into the host’s hepatic and immune system genomes, retains liver pro-oncogenic potency and is
capable of transmitting liver pathogenic infection. This emphasizes the role for primary occult hepatitis B virus infection in
the development of seemingly cyptogenic HCC in seronegative but virus DNA reactive patients.
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Introduction
It is estimated that 370 million people have serologically evident
chronic hepatitis B virus (HBV) infection and over 2 billion have
been exposed to this virus [1]. Chronic hepatitis B (CHB)
frequently (20–25%) advances to cirrhosis and liver failure, while
hepatocellular carcinoma (HCC) develops in approximately 5% of
the cases [1]. HBV is considered to be primarily hepatotropic;
however, it also infects cells of the immune system where it persists
for decades even when hepatitis resolves [2–4]. These events are
closely mimicked in the natural animal model of HBV infection,
the eastern North American woodchuck infected with woodchuck
hepatitis virus (WHV) [4,5].
WHV invariably invades the immune system and persists there
for life irrespective of whether infection is symptomatic and
serologically evident, i.e., serum WHV surface antigen (WHsAg)
and antibody to WHV core antigen (anti-WHc) positive, or
asymptomatic and serologically silent, i.e., serum WHsAg and
anti-WHc nonreactive [6–9]. Based on the findings in naturally
and experimentally WHV-infected woodchucks, two forms of
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occult hepadnaviral persistence were uncovered. Secondary occult
infection (SOI) continuing after resolution of acute hepatitis (AH)
and apparent clearance of serum WHsAg is accompanied by
lifelong persistence of anti-WHc and WHV DNA in serum, liver
and immune system [5–7]. The liver in SOI can display moderate
inflammation with periods of normal morphology; nonetheless
HCC develops in up to 20% of animals [7]. This form of infection
appears to commonly underlie reactivation of hepatitis B in
immunocompromised patients and those on cytotoxic therapies
[10] and development of HCC in individuals with past exposure to
HBV [11,12].
Another form of hepadnaviral persistence, primary occult
infection (POI), was uncovered in offspring of woodchuck dams
convalescent from AH and in animals inoculated with WHV doses
#103 virions [6–9]. POI progresses in the absence of identifiable
serum WHsAg, anti-WHc and antibodies to WHsAg (anti-WHs),
and hepatitis, but WHV and its replication are detectable at low
levels in the immune system and sporadically in the liver [6,9,13].
Virus-specific T cell, but not B cell, responses are induced and,
unlike SOI, protective immunity is not established. Our recent
study showed that repeated exposures to liver nonpathogenic
WHV amounts, i.e., #103 virions, do not culminate in serolog-
ically detectable infection and hepatitis or generate immune
protection [13]. This type of infection can be suspected in HBV
DNA reactive individuals who are seronegative for HBV surface
antigen (HBsAg) and antibodies to HBV core antigen (anti-HBc)
[14].
The main objective of the current study was to identify lifelong
liver pathological consequences of POI, given the known high
oncogenic potency of WHV and HBV [4,15] and the notion that
occult HBV infection undetectable by clinical testing might be
responsible for HCC of unknown etiology in some cases [11,12].
We also aimed to identify characteristics of POI regarding virus
transmissibility and pathogenic potency in virus-naı¨ve hosts, the
status of WHV DNA-host genome integration during POI, and
compatibility between virus sequences occurring in the liver virus-
negative and the liver virus-positive phases of POI.
Materials and Methods
Ethic Statement
All animal experiments and the animal maintenance protocols
were performed in compliance with the Institutional Animal Care
Committee at Memorial University, St. John’s, Newfoundland and
Labrador, Canada (protocol identification number 13–159-M)
that follows the guidelines and is accredited by the Canadian
Council on Animal Care in Science.
Animals, Induction of POI and Sample Collections
Infection experiments were carried out in 1–2 year old healthy
woodchucks housed in the Woodchuck Viral Hepatitis Research
Facility at Memorial University, St. John’s, Newfoundland and
Labrador, Canada. All the animals were captured from a pristine
region of Northern Canada. Normal liver function and morphology
was ascertained by testing serum biochemical markers of hepatic
performance, including sorbitol dehydrogenase (SDH) and c-
glutamyl transferase (GGT), macroscopic inspection of the liver
during laparotomy, and by histological examination of liver biopsy
taken prior to initiation of the study. Prior exposure to WHV was
excluded by negative testing for serum WHsAg and anti-WHc, and
by the absence of WHV DNA as determined by highly sensitive
polymerase chain reaction/nucleic acid hybridization assays (PCR/
NAH) (sensitivity#10 copies or virus genome equivalents [vge]/mL
or #10 vge/mg total DNA) [7–9]. WHV/tm3 inoculum (GenBank
accession number AY334075 for 3 identical clones) induced serum
WHsAg-positive hepatitis in.90% of woodchucks after intravenous
(i.v.) administration of doses $103 DNase-digestion protected vge,
i.e., virions [7–9]. WHV/tm5 inoculum (GenBank accession
numbers KF874491-3 for 3 clones) was derived from a woodchuck
with chronic hepatitis and HCC. WHV/tm5 whole genome
sequencing showed 99.7% (3298/3308) and 99.58% (1668/1675)
identity in the nucleotide (nt) and amino acid sequences, respectively,
when compared to WHV/tm3. Prior to infection, WHV/tm5 was
fractionated on cesium chloride gradient to separate virions from
free WHsAg, essentially as reported [8]. The recovery of intact
virions was ascertained by a DNase-digestion protection assay [2].
To induce POI, 3 animals were i.v. injected with 10 virions of
WHV/tm5 and 7 others with 100 virions of WHV/tm3. In addition,
2 animals inoculated with 106 WHV/tm5 virions, 2 inoculated with
1010 WHV/tm3 virions, and 2 healthy woodchucks not exposed to
WHV, all followed for duration of their lifespan, served as controls.
The animals were bled biweekly until 16 weeks post-infection (w.p.i.)
and then bimonthly. They were followed for life until senility
(animals 1/F, 3/F, 7/M, 10/M and 12/F), HCC development (5/
M, 9/M and 11/M), a WHV-unrelated severe health issue requiring
termination of follow-up (2/F, 8/M and 14/F) or challenge with
1010 virions WHV/tm3 at 66 months post-infection (m.p.i.) (4/F, 6/
M and 13/F). The last group of animals was observed for an
additional 5.2 months, and bled biweekly until 14 weeks post-
challenge (w.p.c.) and then monthly. Liver biopsies were obtained
before WHV inoculation and at 6 w.p.i., 8 m.p.i. and then at
approximately yearly intervals until autopsy. At autopsy, serum,
peripheral blood mononuclear cells (PBMC), liver, bone marrow,
spleen, lymph nodes and other organ samples were collected.
Infection with WHV Derived from Liver Virus-Negative
and Liver Virus-Positive Phases of POI
WHV inocula were prepared from the liver virus DNA-negative
and the liver virus DNA-positive phases of POI by pooling 24 mL of
serum and plasma from 6/M and 7/M, and from 8/M that was
liver WHV DNA nonreactive for life. Pellets recovered by
ultracentrifugation at 200,0006 g for 20 hours at 4uC were
Author Summary
Introduction of highly sensitive molecular assays for
detection of hepatitis B virus (HBV) identified the existence
of persistent occult HBV infection years after recovery from
an episode of hepatitis B and in individuals exposed to
HBV but without symptoms and classical markers of
infection. Because HBV integrates into human DNA and
is a potent human carcinogen, it is postulated that occult
HBV infection can be a cause of hepatic cancer in many
individuals in which the tumor origin remains currently
unknown. A causative relation between occult HBV
infection and hepatocarcinoma is highly challenging to
investigate in humans since occult HBV persistence is
rarely diagnosed with current clinical assays and cancer
development takes 15–30 years. However, we have
established excellent models of occult HBV infection in
the eastern North American woodchucks which are
naturally susceptible to a virus closely related to HBV
and in which chronic infection advances to liver cancer. In
the current study, exploring experimental primary occult
infection in woodchucks, we proved that the silently
progressing infection, which is not detectable by serolog-
ical markers, can culminate in hepatocellular carcinoma
and that the persisting virus remains infectious, and causes
hepatitis and liver cancer when transmitted to virus-naı¨ve
hosts.
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suspended in 1.3 mL of sterile phosphate buffered saline, pH 7.4.
One mL of suspension was i.v. injected into a virus-naı¨ve
woodchuck and 0.3 mL used for WHV quantification and
sequencing. Thus, A/F animal was injected with 1370 vge from
6/M, C/F with 1460 vge from 7/M, and E/F with 1460 vge from
8/M, all obtained from the liver virus-negative phase of POI. Also,
B/F was infected with 2070 vge from 6/M and D/F with 1460 vge
from 7/M collected from the liver virus-positive phase of POI. As a
control, F/F was injected with 1010 virions of WHV/tm3. Plasma
and PBMC samples were collected weekly until 8 w.p.i., biweekly
until 6 m.p.i, and then bi-monthly. Liver samples were obtained
before inoculation, 6–7 w.p.i., 6 m.p.i., then yearly, and at autopsy.
Sample Processing
PBMC and plasma were harvested from sodium EDTA-treated
blood after density gradient centrifugation [7–9]. PBMC were
cryopreserved, and serum and plasma samples stored at 220uC.
Liver samples obtained at biopsy or autopsy were washed, snap
frozen and stored at 280uC. For histological examination, liver
samples were processed to paraffin, stained and hepatic inflamma-
tory alterations enumerated [7,8]. Liver neoplastic changes were
assessed following morphological criteria reported before [7,16].
Serological Assays
WHsAg, anti-WHc were evaluated by enzyme-linked immuno-
sorbent assays (ELISA) reported previously [7–9,13], with
sensitivities comparable to or greater than those of clinical assays
for detection of equivalent HBV infection markers. The sensitivity
of WHsAg ELISA was 3.25 ng/mL while anti-WHc were
detectable up to end-point dilution of 1:64,000. Serum SDH
served as a biochemical measure of liver injury and serum GGT as
an indicator of HCC development [7,13].
WHV DNA, cccDNA and RNA Detections
DNA from 100–400 mL of serum or plasma and from PBMC,
liver, bone marrow and lymph nodes was extracted by the
proteinase K-phenol-chloroform method [6,7]. WHV DNA was
assessed by direct and, if negative, nested PCR/NAH using primers
and conditions reported [7–9]. Each sample was tested with 3
primer sets specific for WHV core (C), envelope (S) and X genes [7–
9]. For nested PCR/NAH detecting WHV covalently closed
circular DNA (cccDNA) (sensitivity, ,102 copies/mL), enzymatic
treatment, primers and conditions previously established were
applied [8,13]. Detection of WHV cccDNA was verified by
sequencing. WHV RNA was detected by reverse transcription-
PCR (RT-PCR; sensitivity, ,10 copies/mL) using RNA extracted
with Trizol (Invitrogen Life Technologies, Burlington, Canada),
treated with DNase (Sigma-Aldrich, Oakville, Canada), and
reversely transcribed to cDNA [8,13]. Each test RNA sample
without reverse transcriptase added served as a DNA contamination
control [8,13]. In selected cases, WHV DNA was quantified by real-
time PCR (sensitivity, 10–100 vge/mL) using DNA equivalent to
25 mL of plasma or 400 ng of total DNA from cells or tissues, and
WHV C and X gene primers. For all assays testing WHV DNA or
RNA presence, mock extractions and respective nucleic acid
preparations from WHV-positive and WHV-negative woodchuck
livers or PBMC were routinely included as controls [6–8]. NAH
analysis of PCR products was always performed to verify the
specificity of virus detection and the validity of controls [6–8].
WHV DNA Sequencing
Low levels of WHV DNA in POI made full virus genome
amplifications unfeasible, therefore fragments amplified with C, S
and X gene-specific primers and regions spanning WHV polymerase
(P) gene between nucleotides (nt) 2948-407 and 1080–1755, X/preC
region nt 1503–2122 and preS nt 2948-407 were sequenced (nt
positions according to WHV/tm3 AY334075 in GenBank). These
regions were selected because they were found to have the most
variable sequence based on analysis of full-length WHV genomes
using Sequencher v5 (Gene Codes Corporation, Ann Arbor, MI).
Amplicons were cloned using the TOPO-TA system (Invitrogen).
Ten clones per amplicon were sequenced bidirectionally [17]. The
same variants found in at least 2 clones were reported.
Inverse-PCR for Identification of Virus-Host and Virus-
Virus Genome Junctions
Liver and bone marrow DNA of 10–20 kbp purified from agarose
served as a template for inverse-PCR (invPCR), as reported [18]. To
identify WHV X region-host genome junctions, DNA was digested
with Nsi-I that cuts WHV at nt 1915 (nt positions according to
WHV/tm3 AY334075 in GenBank) and the woodchuck’s sequence
at unknown sites. To detect WHV preS region-host genome
junctions, DNA was treated with EcoR-I that cuts WHV/tm3 at nt
3308/1. Diluted digests were circularized with T4 DNA ligase and
linearized with Sph-I (for X invPCR) or Pst-I (for preS invPCR). The
possibility of self-ligated virus double-stranded DNA was excluded by
Psi-I or Pml-I digestion. Primers were designed based on consensus
sequence of WHV isolates identified in this laboratory (GenBank
accession numbers: AY334075, AY6280 and GU734791). For the X
region, direct and nested primer pairs were located at nt 1782–1808
and 1718–1737, and 1853–1876 and 1654–1673, respectively. For
the preS region, direct primers were located at nt 3231–3253 and
3009–3028, and nested primers at 3202–3222 and 2964–2985. The
bands carrying WHV sequences were identified by NAH. DNA was
purified by excision from agarose and either directly sequenced
bidirectionally or cloned and sequenced. Non-WHV sequences were
analyzed with NCBI BLAST and Refseq (National Center for
Biotechnology Information, Bethesda, MD). WHV sequences were
mapped by aligning with the full-length WHV/tm3 using BioEdit
(Ibis Biosciences, Carlsbad, CA).
Accession Numbers
WHV sequences derived from the liver WHV-negative and liver
WHV-positive phases of POI reported in this study were submitted
to GenBank under accession numbers KJ755421 for woodchuck 6/
M and KJ755420 for 7/M. WHV sequences identified in plasma
and spleen of 8/M animal with POI have GenBank accession
numbers KJ755405, KJ755406, KJ755410, KJ755411, KJ755415
and KJ755416, while those in E/F woodchuck injected with plasma
inoculum derived from 8/M animal have GenBank accession
numbers KJ755407-KJ755409, KJ755412-KJ755414, and
KJ755417-KJ755419. WHV genome-woodchuck DNA integration
sites identified in livers and bone marrows of animals with POI
which developed HCC have accession numbers KG817076-85,
KG817088, KG817089, KG817091 and KG817092, and those
found in livers, PBMC and lymphoid tissues in woodchucks with
POI without HCC have accession numbers KG817074, KG817075,
KG817086, KG817087, KG817090, and KG817093-99. The
sequence of woodchuck HCC H19 gene fragment identified in this
study has GenBank accession number KG8117082.
Results
Exposure to a Single Small Dose of WHV Establishes
Lifelong Serologically Silent but Molecularly Evident
Infection
Animals inoculated with 10 or 100 virions of WHV/tm5 or
WHV/tm3, respectively, showed no serological evidence of WHV
Primary Occult Hepadnaviral Infection and HCC
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infection for up to 5.5 years p.i., as revealed by undetectable serum
WHsAg and anti-WHc (Figs. 1A and 1B). Nonetheless, WHV DNA
was detected in serum/plasma and PBMC throughout the entire
follow-up at levels of 100–200 vge/mL or ,103 vge/mg cell DNA,
respectively (Figs. 1A and 1B). In contrast, woodchucks injected
with 106 or 1010 virions developed transient serum WHsAg
Figure 1. Lifelong profiles of serological markers of WHV infection and WHV DNA detection in serum, PBMC and liver tissue
samples, and the results on liver histology in woodchucks injected with a single dose of 10 WHV/tm5 or 100 WHV/tm3 virions and
in control animals infected with a liver pathogenic dose of 106 or 1010 virions of the same inocula, respectively. (A) Three healthy,
WHV-naı¨ve animals i.v. injected with 10 virions recovered after isopynic banding from WHV/tm5 inoculum were followed for life or up to 66 months
post-infection (p.i.). (B) Seven healthy, WHV-naı¨ve animals were i.v. injected with 100 DNase-digestion protected virions of WHV/tm3 inoculum. The
animals were followed for life or until challenge with a liver pathogenic dose of 1010 WHV/tm3 virions at 66 months p.i., as indicated by dotted line.
(C) Two healthy woodchucks were injected with 106 WHV/tm5 virions and 2 others with 1010 WHV/tm3 virions as controls and followed for life or until
challenge with WHV/tm3. The appearance and duration of WHsAg (dotted bars) and anti-WHc (black bars) reactivity in sequential serum samples and
WHV DNA in serum and PBMC samples are shown. The estimated levels of WHV DNA detected in sera and PBMC are as follows: white bar, ,10 vge
per mL or mg DNA, grey bar, 100–200 vge per mL or mg DNA, and black bar, 200–1000 vge per mL or mg DNA. Liver biopsies were obtained at the time
points indicated by the solid black arrowheads and their estimated loads of WHV DNA are presented in vge/mg of total DNA. Liver inflammatory
alterations were graded by histology on a scale from 0 to 3.
doi:10.1371/journal.ppat.1004332.g001
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positivity, anti-WHc for life, and biochemical (not shown) and
histological evidence of self-limited AH (SLAH) (Fig. 1C). WHV
cccDNA and/or WHV RNA were identified in PBMC (Fig. 2 and
Fig. 3A) throughout the lifespan and in lymphoid organs at autopsy
in woodchucks with POI (Fig. 3B), similarly as in animals with
lifelong SOI continuing after SLAH and as reported [7–9].
Sequential plasma or serum, liver and PBMC samples from healthy
WHV-naı¨ve woodchucks serving as controls remained WHV DNA
negative when tested by nested PCR/NAH, while the animals liver
and PBMC samples were WHV RNA nonreactive by nested RT-
PCR/NAH during the entire observation period (data not shown).
POI Engages Liver over Time and Causes HCC
It was not until 32 to 40 m.p.i. that all animals injected with 10 or
100 virions became consistently liver WHV DNA reactive (Fig. 1)
and showed evidence of hepatic WHV replication, i.e., detection of
WHV cccDNA or WHV RNA or both (Fig. 2). However, 9/M
showed transiently a low level of virus DNA in the liver at 6 w.p.i.,
while 1/F and 5/M were reactive from 26 m.p.i and 6 w.p.i.
onwards, respectively (Figs. 1A and 1B). Liver samples from 2/F
and 8/M were consistently WHV DNA negative, even up to
autopsy performed at 22 and 34 m.p.i., respectively. Liver histology
and serum SDH levels remained entirely normal during the whole
follow-up, except minimal inflammatory lesions limited to a few
portal areas found at 32 m.p.i. in 5/M and at autopsy in 1/F and
10/M (Fig. 1). Despite this infection pattern, typical multinodular
HCC has developed in 5/M and 9/M at 55 m.p.i. (Fig. 1B). The
diameter of tumor nodules ranged between 2–3 mm (numerous) to
1.5–2 cm (singular) and they were spread throughout the entire
livers. Histological examination revealed foci of well-differentiated
HCC with hepatocytes arranged in trabeculea (Fig. 4) and,
occasionally, with regions of compact cancer tissue. The HCC
appearance coincided with moderately elevated serum GGT levels
(data not shown). Control woodchucks injected with liver patho-
genic doses of WHV showed transiently elevated serum SDH (data
not shown) and SLAH followed by SOI accompanied by persistent
low-level WHV replication in both liver and PBMC, and
intermittent minimal to mild liver inflammation (Fig. 1C), as
reported [7,9]. One of the woodchucks (11/F) inoculated with 106
virions of WHV/tm5 developed HCC at 70 m.p.i. (Fig. 1C).
Healthy controls not exposed to WHV had normal serum SDH and
GGT levels during follow-up. Their livers remained normal during
their lifespan when inspected macroscopically during laparotomies
and by histological examination of serial biopsies obtained at
approximately yearly intervals (data not shown).
WHV from Liver Virus-Negative and Liver Virus-Positive
Phases of POI Is Infectious, Liver Pathogenic and Displays
Essentially the Same Sequence
To determine whether virus persisting as POI retained its
infective and pathogenic properties, WHV recovered by ultracen-
trifugation from pooled serum/plasma collected from the liver
WHV-negative or the liver WHV-positive POI phases was
administered at doses between 1370 and 2070 virions to virus-
Figure 2. Detection of WHV cccDNA and WHV RNA in liver and PBMC samples obtained at 34–40 months post-infection from
woodchucks with POI established by inoculation with 10 WHV/tm5 virions. For detection of WHV cccDNA (top panel), total DNA from
PBMC (P) or liver (L) was digested with a single-strand-specific nuclease and amplified by PCR with primers spanning the nick genomic region of WHV.
Southern blot hybridization was applied to validate controls and confirm specificity of the 674-bp amplicons. For the detection of WHV RNA (bottom
panel), DNase-treated total RNA was reverse transcribed (RT+) or not (RT2) prior to PCR amplification with WHV X gene-specific primers. The
specificity of 192-bp amplicons and controls was confirmed by Southern blot hybridization analysis. In both panels, contamination controls consisted
of water added to direct (DW) and nested (NW) reactions instead of test DNA or cDNA. Mock samples (M) were extracted and treated as test samples
in all steps. DNA and RNA from the liver of a serum WHsAg-positive woodchuck with chronic hepatitis served as positive controls, respectively.
doi:10.1371/journal.ppat.1004332.g002
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Figure 3. Detection of WHV cccDNA and RNA in liver and lymphoid cell and tissue samples obtained from woodchucks with
lifelong POI established after inoculation with 100 virions of WHV/tm3. (A) Identification of WHV cccDNA in PBMC (P) and liver (L) biopsies
(top panel) and WHV RNA in the liver biopsies (bottom panel) obtained at 32 months post-infection from 4/F, 5/M and 6/M with POI and from control
animal 13/F. (B) Detection of WHV cccDNA (top panel) and WHV RNA (bottom panel) in bone marrow (BM), PBMC (P), lymph node (LN) and in liver (L)
samples collected at autopsy from woodchucks 5/M, 9/M and 10/M with POI followed for 54–55 months p.i. with 100 virions of WHV/tm.3. Procedural
details, specificity and contamination controls, and their verification were as those described in the legend to Figure 2 and in Materials and Methods.
doi:10.1371/journal.ppat.1004332.g003
Primary Occult Hepadnaviral Infection and HCC
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naı¨ve woodchucks. All animals developed transiently serum
WHsAg-positive infection from 57–84 d.p.i. lasting for up to
113 d.p.i (Fig. 5). The WHsAg appearance was delayed by 22–49
days when compared to F/F control injected with 1010 virions.
Anti-WHc became detectable at 70–113 d.p.i. (at 57 d.p.i. in F/F)
and persisted to the end of follow-up. In animals inoculated with
WHV from the liver virus-negative phase of POI, hepatic WHV
load at 7 w.p.i. ranged from 30 to 100 vge/mg DNA, whereas in
those with WHV from the liver virus-positive phase between
2.56103 and 1.16106 vge/mg DNA (9.56106 vge/mg DNA for F/
F). However, subsequent liver biopsies showed comparable WHV
DNA levels ranging between 26102 and 26103 vge/mg DNA.
Similar WHV DNA loads were detected in sera (10-102 vge/mL)
and PBMC (10-102 vge/mg DNA) from the beginning of infection
regardless of the inoculum source, but these levels subsequently
increased by 10–100-fold. All animals (n = 5) developed mild to
minimal hepatitis that persisted through the observation period
(Fig. 5). Interestingly, 3 of them, including two inoculated with
WHV from the liver virus-negative POI phase, developed HCC
within 4.5 to 35 m.p.i. accompanied by a variable degree of
hepatitis (Fig. 5).
To recognize whether initiation of the liver virus-positive phase of
POI might be related to the emergence of a specific WHV variant,
2060-bp of WHV sequences derived from the liver virus-negative
and liver virus-positive phases of POI from 6/M and 7/M were
compared. The results showed that the WHV sequence from the
liver-virus negative phase of 6/M differed only by one non-
synonymous mutation in the preC region when compared to that of
the virus from the liver virus-positive phase (Table 1). When WHV
sequences from the equivalent phases from 7/M were compared,
WHV from the liver virus-negative period showed 5 non-
synonymous mutations not encountered in the virus from the liver
WHV-positive phase (Table 1). However, none of the mutations
were compatible with that identified in the preC region of 6/M
WHV sequence, suggesting that unlikely a unique hepatotropic
variant initiated the liver virus-positive phase of POI.
To determine whether WHV derived from the liver-virus
negative POI phase retained its sequence after administration to a
virus-naı¨ve host, WHV sequences in inoculum and spleen from 8/
M, which remained liver virus-negative until autopsy (Fig. 1B), and
WHV from plasma, PBMC and liver from E/F, which was injected
with 8/M inoculum (Fig. 5), were compared to each other and to
WHV/tm3. This analysis showed that 2060-bp of the WHV
sequence from 8/M inoculum and spleen displayed very few point
mutations when compared to WHV/tm3 (11/2060), 8 conferred
amino acid changes and 6 occurrrd in both samples (Table 2).
WHV sequences from serum and liver of E/F were highly
compatible to that of 8/M inoculum, while E/F PBMC showed a
number of non-synonymous variants which were unaccounted for
in WHV/tm3 inoculum (n = 31), 8/M inoculum (n = 25) or E/F
serum or liver (n = 21) (Table 2), suggesting that the virus after
transmission propagated most actively in the lymphoid cells.
POI Is Accompanied by WHV DNA Integration into Host’s
Liver and Lymphatic System Genomes
Multiple WHV DNA-host genome junctions were identified in
animals with POI which developed HCC (5/M and 9/M) or not
(1/F, 2/F, 7/M and 10/M) (Table 3). Among virus-host
integrants detected in liver biopsy and autopsy samples from 5/
M and 9/M, various host sequences were joined predominantly
with WHV X gene and less often with the polymerase (P) gene,
and preS region sequences (Table 3). None of the virus-host
integration sites was identified more than once in the material
investigated; however, particular junctions were frequently found
Figure 4. Histological characteristics of HCC in 5/M and 9/M
woodchucks at 55 months post-inoculation with 100 WHV
virions. (A–C) Representative alterations encountered in cancerous
liver tissue of animal 5/M and (D–F) in animal 9/M. Well-defined
trabeculae formed by hepatocyte-like cells are evident and demarked
with dashed lines (B and F) or by arrows (B). Arrow heads point at
frequently observed binuclear cells resulting from cell divisions (C).
Accumulation of lipid droplets is apparent in almost all hepatocytes of
both animals. Hepatic tissue was obtained at autopsies done in the late
fall at the time when storage of fat in the liver is completed prior to
physiologically occurring hibernation, although the animals were awake
and physically active during the study period. Paraffin sections stained
with hematoxylin-eosin. Original magnifications x100 for A and D and
x250 for B, C, E and F.
doi:10.1371/journal.ppat.1004332.g004
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in more than one clone (Table 3). Notably, in HCC tissue from 9/
M, the 264-bp host sequence flanked by the virus X gene sequence
showed 80% homology with mouse H19 cDNA (GenBank
accession number AF214115.1). H19 is a tumor suppressor gene
and its knockdown may play a role in HCC development [19].
Further to virus-host junctions, multiple virus DNA rearrange-
ments were identified in liver samples from animals with POI-
associated HCC, but less frequently in those without cancer
(Table 3). Viral-host junctions were also detected in autopsy bone
marrow, lymph node and PBMC samples in all 6 animals analyzed
(Table 3).
Long-Term POI Does Not Protect from WHV Reinfection
and Hepatitis
4/F and 6/M with POI lasting for 5.5 years were challenged
with 1010 virions of WHVtm3 to determine whether the animals
might be protected from reinfection. Both woodchucks became
serum WHsAg positive at 2 w.p.c. and remained positive until 18
w.p.c. (Fig. 6). Anti-WHc became detectable from 13–14 w.p.c.
Serum SDH levels increased and peaked at 8–14 w.p.c., while liver
histology displayed moderate to severe AH (Fig. 6). WHV DNA
levels in serum and PBMC were similar to those detected in
control animals over the course of SLAH (Fig. 1C). Additionally,
samples collected from 4/F and 6/M at autopsy, when serum
WHsAg was undetectable, displayed low levels of WHV DNA in
serum, liver and lymphatic organs, implying existence of SOI.
Thus, both 4/F and 6/M developed acute hepatitis despite being
persistently infected with WHV at a low-level. This was in contrast
to 13/F with established SOI, which was protected from challenge
(Fig. 6), similarly as previously reported [7,9,13].
Discussion
We uncovered that minute amounts of hepadnavirus establish
infection that persists indefinitely in the woodchuck model of
hepatitis B in the absence of conventional serological markers of
infection and hepatitis, but is detectable molecularly when
sensitive virus nucleic acid-specific amplification assays are
applied. We also documented that this form of asymptomatically
hepadnaviral carriage, designated previously as POI [5,9,13], has
both pathogenic and epidemiological relevance since it can lead to
the development of HCC and, under certain conditions, transmit
infection and cause hepatitis and HCC in virus-naı¨ve hosts.
Another important finding, albeit expected, was that POI is
associated with hepadnavirus DNA integration into the hepatic
and immune system DNA, which likely underpins liver oncogenic
potency of the virus persisting during the course of this
asymptomatic form of hepadnaviral carriage.
The results from the current investigations also showed that
during POI, WHV replication expands to the liver with time, but
the level and/or type of cells infected appear to be inadequate to
trigger hepatitis. In previous studies, woodchucks with experimental
POI were followed for up to 25 m.p.i. without detection of WHV in
the liver or evidence of HCC, while WHV replication was
detectable in circulating and organ lymphoid cells [9,13]. Also,
offspring born to woodchuck dams with SOI, which acquired
lymphatic system-restricted POI, did not show liver engagement
and the development of HCC during the 42-month observation
period [6]. Although there might be several factors contributing to
the development of HCC during POI, the virus spreading to the
liver and the extended period of POI follow-up appear to be critical.
WHV genome fragments from the liver virus-negative and the
liver virus-positive POI phases showed essentially the same
predicted amino acid sequences (Table 1), which also were highly
compatible to that of wild-type WHV inocula used to induce POI
in this study. We analyzed more than 62% of the total WHV
sequence, including virus regions identified as having the highest
sequence variability based on our preceding analysis of the
complete WHV sequences reported in GenBank. We used this
approach because the trace quantities of WHV found during POI
and the inherently lower sensitivity of the extended PCR
amplifying long WHV sequences made full virus genome
amplification not feasible. We also identified that the WHV/tm3
sequence, as far as we were able to determine, was conserved in
the animals injected with WHV prepared from the liver WHV-
negative or the liver WHV-positive phases of POI, which
developed WHV infection engaging both the liver and the
lymphatic system. These findings imply that the dual tropism of
WHV towards hepatocytes and immune cells is unlikely due to the
existence of cell type-specific viral variants but is an intrinsic
Figure 5. Serological profiles of WHV infection, detection of WHV DNA in sequential serum, PBMC and liver tissue samples,
histological degree of hepatitis, and detection of HCC in initially healthy, WHV-naı¨ve woodchucks inoculated with circulating WHV
derived from the liver virus-negative and the liver virus-positive phases of POI. Animals were i.v. injected with indicated amounts of WHV,
presented in virus genome equivalents (vge), recovered by ultracentrifugation of pools of plasma and serum from the liver WHV-negative and the
liver WHV-positive phases of POI from 6/M and 7/M, and from the liver WHV-negative phase of POI from 8/M woodchuck. A control F/F animal was
injected with 1010 WHV/tm3 virions. The appearance and duration of serum WHsAg and anti-WHc positivity, the estimated WHV DNA loads in sera,
PBMC and liver biopsy and autopsy samples, and liver morphological alterations were presented as indicated in the legend to Figure 1.
doi:10.1371/journal.ppat.1004332.g005
Table 1. Unique non-synonymous mutations identified in circulating WHV derived from the liver virus-negative phase but not
from the liver virus-positive phase of POI from 6/M and 7/M woodchucks.
PreS Polymerase X PreC
766 bp (nt 2949-407) 1441 bp (nt 2949-407 & 1080–1755) 425 bp (nt 1503–1928) 212 bp (nt 1910–2122)
3/M n.d. n.d. n.d. V25F
4/M A91N, T93N, P181L S279K, N281L n.d. n.d.
For each of the WHV genome fragments sequenced, its length (bp) and location (nt) were enumerated according to the WHV/tm3 sequence (GenBank accession
number AY334075). The amino acid change and location of each of the non-synonymous mutations identified were based on the predicated amino acid sequence of
WHV/tm3. Only variants detected in 2 or more of 10 clones are reported.
Abbreviation: n.d. not detected.
doi:10.1371/journal.ppat.1004332.t001
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propensity of the naturally occurring virus. This is consistent with
data from in vitro infection experiments in which the same wild-
type WHV was serially passaged in cultured woodchuck hepato-
cytes and lymphoid cells [17]. This issue has not yet been
investigated in HBV infection.
Our previous studies showed that serologically overt WHV
infection coinciding with hepatitis is resultant from i.v. adminis-
tration of WHV doses greater than 16103 virions (liver pathogenic
doses), while lower doses of the same wild-type virus (liver non-
pathogenic doses) consistently induced POI in woodchucks [9,13].
In the current study, concentration by ultracentrifugation of virus
from animals with POI to levels above the previously identified
liver pathogenic threshold was accomplished and, as documented,
the recovered virus readily induced serologically overt infection
and hepatitis upon transmission to virus-naı¨ve animals (see Fig. 5).
It appears that the inability of WHV to engage the liver during the
initial phase of POI was related to the very low quantities of the
produced virus which, however, can be temporally augmented to
the level sufficient to invade the liver. In this regard, we detected a
transient increase in plasma WHV load to approximately or above
16103 vge/mL that preceded detection of WHV DNA and its
replication intermediates in hepatic tissue. It can be assumed that
this temporal increase in circulating WHV was adequate to engage
the liver during later phase of POI, which prior to that was
restricted to the lymphatic system. This appears to be consistent
with identification of a 100 to 1000-fold greater affinity of
synthetic analogues of WHV cell binding site for activated
woodchuck lymphoid cells than woodchuck hepatocytes, suggest-
ing that very low quantities of virus may preferentially invade the
immune system [20,21].
The mechanism of liver carcinogenesis in hepadnaviral
infection is not well understood, but it is likely a multistep process
in which persistent virus infection and virus genome integration
into host DNA are among the principal contributors [22].
Random HBV DNA integration into the liver genome was found
in up to 22% of patients with CHB and is a typical finding in
HBV-related HCC (.80% patients) [22–24]. On the other hand,
the status of HBV DNA integration into HCC DNA coinciding
with occult HBV infection was only occasionally investigated and
mainly in cirrhotic patients [11,12]. Nonetheless, the data
convincingly showed that HBV DNA integrates into both HCC
and non-HCC liver DNA in serum HBsAg-negative patients, with
or without detectable anti-HBc [11,12]. In WHV-related HCC,
virus DNA insertions were identified in tumors developing during
chronic hepatitis and SOI continuing after SLAH [25]. WHV
DNA integration was frequently found near the myc pro-
oncogenes in HCC coinciding with chronic WHV hepatitis
[26,27]. We did not find this relation in woodchucks developing
HCC during POI. However, this might become more apparent
when a greater number of relevant cases are analyzed. About two-
thirds of the virus-host genome junctions detected in this study
encompassed the WHV X gene sequence (Table 3). This
resembles the predisposition of HBV X gene to integrate into
the host genome reported in serum HBsAg-negative patients with
HCC [28]. In our study, HCC had developed in the absence of
hepatitis and cirrhosis. In contrast to CHB, chronic WHV
hepatitis never leads to cirrhosis and very rarely to fibrosis (,
1%) [4]. However, the occurrence of HBV-related HCC in the
absence of cirrhosis has been reported [28]. The present finding of
the POI-associated HCC mimics the human disease situation
where HBV-related HCC develops in the absence of apparent
chronic liver disease and serological evidence of HBV infection.
Notably, the finding of WHV DNA sequence insertions within
bone marrow DNA in POI parallels HBV DNA and WHV DNA
integration into lymphoid cells and lymphatic organ genomes in
CHB and in woodchucks with chronic hepatitis and SOI [29,30].
This study also revealed that POI during lifelong follow-up did
not culminate in serologically apparent infection or hepatitis, and
did not induce protective immunity. These findings add new
dimensions to the previous investigations on POI [6,9,13]. Among
others, our previous study showed that repeated i.v. injections (12
in total) with 100 WHV virions did not initiate serologically
detectable infection or hepatitis, but molecularly evident POI was
established and continued until challenge with a liver pathogenic
dose (.103 virions) of the same virus inoculum [13]. In the current
study (data not shown) and in the previous investigations
[9,13,31,32], WHV-specific T cell reactivity occurring in the
absence of virus-specific antibody response did not protect from
challenge with liver pathogenic doses of WHV (.103 virions). This
is in marked contrast to WHV-specific T cell responses coinciding
Table 2. Non-synonymous mutations identified in WHV sequence of the inoculum prepared from the liver WHV-negative phase of
POI and in the spleen from 8/M donor and in serum, PBMC and liver of E/F recipient injected with this inoculum.
PreS Polymerase X PreC
766 bp (nt 2949-407) 1441 bp (nt 2949-407 & 1080–1755) 425 bp (nt 1503–1928) 212 bp (nt 1910–2122)
Donor 5/M
Inoculum V179L (0.13%) S368T, G672D, I689M (0.21%) T12A, S22G (0.47%) F11L, G37D (0.94%)
Spleen V179L (0.13%) N289Y, S368T, G672D, I689M (0.28%) T12A, S22G (0.47%) F11L (0.47%)
Recipient E/F
Serum P103L, V179L (0.26%) S368T, G672D, I689M (0.21%) T12A, S22G (0.47%) F11L (0.47%)
PBMC T26P, V47I, T51N, N83S,
P103L, H169Q, D174N,
V179L, I189T, Q201L (1.3%)
V204M, H206Y, N214T, D227N, S233L,
N234K, R239K, H247Y, T267I, N289Y,
L293R, K348T, T359P, K362R, D366N,
S368T, I381L, G672D, I689M (1.3%)
T12A, S22G (0.47%) F11L (0.47%)
Liver D174N (0.13%) N289Y, K362R, S368T, G672D, I689M (0.35%) T12A, S22G (0.47%) F11L, G37D (0.94%)
For each of the WHV genome fragments sequenced, its length (bp) and location (nt) were enumerated according to the WHV/tm3 sequence (GenBank accession
number AY334075). The amino acid change and location of each of the non-synonymous mutations identified were based on the predicated amino acid sequence of
WHV/tm3. Only variants detected in 2 or more of 10 clones are reported. The number of amino acid changes found in a given WHV genomic region is presented as
percentage of the total number of residues in the sequence analyzed.
doi:10.1371/journal.ppat.1004332.t002
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with virus-specific antibodies in SOI continuing after recovery
from symptomatic WHV infection and hepatitis which yield total
protection against challenge with even massive doses of WHV (.
1010 virions) [7,31]. The former may parallel a situation in
unvaccinated individuals having repeated contacts with infected
persons and intravenous drug users repetitively exposed to small
amounts of HBV. Our data implies that these individuals would
unlikely become serum HBsAg and anti-HBc reactive or immune
to HBV infection, but the development of HCC in such persons
cannot be excluded. Nonetheless, the current findings are in
contrast to data indicating that one virion of HBV derived from a
HBV transgenic mouse was able to induce serologically evident
chronic hepatitis in chimpanzee [33]. Differences in the liver
pathogenic potency between a single HBV isolate from a
transgenic mice and intact, naturally occurring WHV might
explain this discrepancy.
Although the existence of POI in humans has not yet been
thoroughly investigated, the prevalence of HBV DNA-reactive
infection seronegative for HBsAg and anti-HBc has been reported
between 0.07 and 7.6% of subjects in different areas of HBV
endemicity [12,34]. It can be expected that HBV POI is much more
frequent because the assays available for HBV DNA detection are
approximately 10–100-fold less sensitive than these utilized in this
study. Further, HBV-specific T cell responses in the absence of
Figure 6. Profiles of serological markers of WHV infection and WHV DNA detection in serum, PBMC and liver tissue samples, and
the results on liver histology in 4/F and 6/M woodchucks with POI and in a control 13F animal with SOI after challenge with a single
1010 virion dose of WHV/tm3. At 66 months post-injection with 100 or 1010 virions of WHV/tm3 (see Figure 1), each woodchuck was challenged
with 1010 WHV/tm3 virions. The appearance and duration of serum WHsAg and anti-WHc positivity, the estimated WHV DNA loads in sera, PBMC and
liver autopsy samples, and liver morphological alterations were presented as described in the legend to Figure 1.
doi:10.1371/journal.ppat.1004332.g006
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serum HBsAg and anti-HBc have been identified in HBV DNA-
reactive patients, further supporting that this silent form of HBV
infection naturally occurs [14]. It is of note that WHV-specific T cell
responses were also examined in the current study and they
persisted at borderline levels after a period of heightened reactivity
lasting between 6 and 20 w.p.i. (data not shown).
In conclusion, this study revealed the oncogenic capacity and
potential epidemiological significance of asymptomatic hepadna-
viral carriage initiated by very small amounts of otherwise
pathogenic virus that advances in the absence of traditional
serological markers of infection and hepatitis. The data emphasize
the role for primary occult HBV infection in the development of
seemingly cyptogenic HCC in HBV seronegative patients.
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